Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 2/20 | 0.37 |
| ▸ | MMP3 | P08254 | 2/20 | 0.37 |
| ▸ | MMP7 | P09237 | 2/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
| ▸ | ECE1 | P42892 | 3/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.31 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10394988 | 0.86 | TAS2R38 (0.36) | MMP2MMP3MMP7MMP1ECE1 | |
| Urea SCHEMBL29215668 | 0.79 | SLC1A3 (0.45) | MMP2MMP3MMP7MMP1ECE1 | |
| SCHEMBL13500189 | 0.79 | MMP2 (0.49) | MMP2MMP3MMP7MMP1 | |
| SCHEMBL3322985 | 0.78 | GRIK1 (0.35) | MMP2MMP3MMP7MMP1ECE1 | |
| SCHEMBL13499675 | 0.77 | MMP2 (0.44) | MMP2MMP3MMP7MMP1ECE1 | |
| SCHEMBL29215667 | 0.76 | MAPT (0.35) | MMP2MMP3MMP7MMP1MAPT | |
| SCHEMBL13461535 | 0.76 | MMP2 (0.38) | MMP2MMP3MMP7MMP1ECE1 | |
| SCHEMBL13435005 | 0.74 | MMP2 (0.43) | MMP2MMP3MMP7MMP1ECE1 | |
| SCHEMBL3651551 | 0.73 | CA1 (0.45) | MAPTECE1CRBN | |
| SCHEMBL3651490 | 0.73 | CA1 (0.45) | MAPTECE1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 466 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118872662-A | Ultralow temperature preservation method of umbilical cord blood mononuclear cells and freezing storage liquid set | 深圳市中佳生物医疗科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-110511141-A | A kind of synthetic method of apronal | SHANGHAI LINKCHEM TECH CO LTD | 2019-11-29 | — | — | CN | claimed |
| CN-107501129-A | A kind of synthetic method of apronal | 陕西师范大学 | 2017-12-22 | — | — | CN | claimed |
| EP-2702989-B1 | STABLE PHARMACEUTICAL COMPOSITION | KOWA CO (JP) | 2017-08-23 | — | — | EP | claimed |
| EP-2702989-A1 | STABLE PHARMACEUTICAL COMPOSITION | Kowa Company, Ltd. (JP) | 2014-03-05 | — | — | EP | claimed |
| US-20120095104-A1 | USE OF VASOCONSTRICTORS | ZACHAR ORON (IL) | 2012-04-19 | — | — | US | claimed |
| CN-102300566-A | Cutaneous application of vasoconstrictors | — | 2011-12-28 | — | — | CN | claimed |
| EP-2376073-A2 | DERMAL APPLICATION OF VASOCONSTRICTORS | Zachar, Oron (IL) | 2011-10-19 | — | — | EP | claimed |
| US-20110144209-A1 | USE OF VASOCONSTRICTORS | ZACHAR ORON | 2011-06-16 | — | — | US | claimed |
| EP-2313037-A1 | DERMAL APPLICATION OF VASOCONSTRICTORS | Zachar, Oron (IL) | 2011-04-27 | — | — | EP | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-1027339-A1 | METHOD AND REAGENTS FOR N-ALKYLATING UREIDES | TARO PHARMACEUTICAL INDUSTRIES LIMITED (IL) | 2000-08-16 | — | — | EP | claimed |
| US-6093820-A | REACTING AN IMIDE WITH A (SUBSTITUTED)ALKOXYALKYLSULFONIC ACID ESTER TO FORM A N-ALKOXYALKYL IMIDE SUCH AS METHOXYMETHYL ETHOSUXIMIDE; ADMINISTERING AS ANTICONVULSANT, ANTIANXIETY AGENT AND MUSCLE RELAXANT | TARO PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2000-07-25 | — | — | US | claimed |
| WO-1999018084-A1 | METHOD AND REAGENTS FOR N-ALKYLATING UREIDES | TARO PHARMACEUTICAL INDUSTRIES LTD. (IL) | 1999-04-15 | — | — | WO | claimed |
| US-5686109-A | MIXTURE OF IBUPROFEN AND ISOPROPYLANTIPYRINE, REDUCED SIDE EFFECTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-11-11 | — | — | US | claimed |
| US-5585243-A | SEPARATELY INCUBATING HUMAN PLATELETS WITH BLOOD SAMPLE ANDREAGENT DRUG SOLUTION TO FORM COMPLEXES, DETERMINING AMOUNT OF BOUND ANTIBODY | THE BLOOD CENTER OF SOUTHEASTERN WISCONSIN, INC. (US) | 1996-12-17 | — | — | US | claimed |
| US-5409709-A | Coating a layer of ibuprofen, a layer of magnesium-based antacid and a layer between the above layers of acetaminophen; sustained release; antiinflammatory agent | LION CORPORATION (JP) | 1995-04-25 | — | — | US | claimed |
| WO-1995008116-A1 | METHOD OF DETECTING CYTOPENIA THAT IS MEDIATED BY DRUG-DEPENDENT ANTIBODY BINDING TO BLOOD CELLS | THE BLOOD CENTER OF SOUTHEASTERN WISCONSIN, INC. (US) | 1995-03-23 | — | — | WO | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |